The significantly higher PLIN2 levels found in female NAFLD patients, mirroring existing literature, suggests that serum PLIN2 may reflect gender-specific differences in adipose tissue distribution or fat metabolism, under scoring its potential role as a sex-dependent metabolic biomarker. The gene discussed is PLIN2; the disease is metabolic dysfunction-associated steatotic liver disease.